References
- Takeda A, Shigematsu N, Suzuki S, et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated‐dose area and severity. Int J Radiat Oncol Biol Phys. 1999;44:599–605. doi:10.1016/S0360-3016(99)00057-710348290
- Matet A, Daruich A, Zografos L. Radiation maculopathy after proton beam therapy for uveal melanoma: optical coherence tomography angiography alterations influencing visual acuity.invest. Ophthalmol Vis Sci. 2017;58(10):3851–3861. doi:10.1167/iovs.17-22324
- Brown G, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ. Radiation retinopathy. Ophthalmology. 1982;89:1494–1501.7162794
- Seregard S, Pelayes DE, Singh AD. Radiation therapy: posterior segment complications. Dev Ophthalmol. 2013;52:114–123.23989132
- Finger PT, Chin KJ. High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy. Eur J Ophthalmol. 2013;23:850–856. doi:10.5301/ejo.500033323813109
- Finger PT, Chin KJ, Semenova EA. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study. Eur J Ophthalmol. 2016;26:60–66. doi:10.5301/ejo.500067026391167
- Mashayekhi A, Rojanaporn D, AL-Dahmash S, Shields CL, Shields JA. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma. Eur J Ophthalmol. 2014;24:228–234. doi:10.5301/ejo.500035223934823
- Kikyoun JL. Long term visual acuity results of treated and untreated radiation retinopathy (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106:325–335.19277244
- Tarmann L, Langmann G, Mayer C, Weger M, Haas A, Wackernagel W. Ozurdex reduces the retinal thickness in radiation maculopathy refractory to bevacizumab. Acta Ophthalmol. 2014;92:e694–e696. doi:10.1111/aos.1242424739457
- Shields CL, Demirci H, Dai V, et al. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma. Retina. 2005;25:868–874.16205566
- Hurtikova K, Gerding H. Combined laser photocoagulation and anti-VEGF injection treatment in radiation retinopathy. KlinMonblAugenheilkd. 2017;234(4):515–519.
- Ohr M, Kaiser PK. Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration. Expert Opin Pharmacother. 2012;13(4):585–591. doi:10.1517/14656566.2012.65836822300011
- Avitabile T, Azzolini C, Bandello F, et al. Aflibercept in the treatment of diabetic macular edema: a review and consensus paper. Eur J Ophthalmol. 2017;27(6):627–639. doi:10.5301/ejo.500105329077188
- Parsons JT 1, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30(4):765–773. doi:10.1016/0360-3016(94)90347-67960977
- Monroe AT 1, Bhandare N, Morris CG, Mendenhall WM. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys. 2005;61(3):856–864. doi:10.1016/j.ijrobp.2004.07.66415708266
- Pooprasert P, Young-Zvandasara T, Al-Bermani A. Radiation retinopathy treated successfully with aflibercept. BMJ Case Rep. 2017;2017. doi:10.1136/bcr-2017-220744
- Fallico M, Reibaldi M, Avitabile T, et al. Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1547–1554. doi:10.1007/s00417-019-04347-631081526
- Loukianou E, Loukianou G. Intravitreal aflibercept in recalcitrant radiation maculopathy due to external beam radiotherapy for nasopharyngeal cancer: a first case report. Case Rep Ophthalmol. 2017;8(1):87–90. doi:10.1159/00045653528413405
- Murray TG, Latiff A, Villegas VM, Gold AS. Aflibercept for Radiation Maculopathy Study: A Prospective Randomized Clinical Study. Ophthalmol Retina 2019;3(7):561–566.
- Sivaprasad S, Prevost AT, Bainbridge J, et al. Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial. BMJ Open. 2015;5(9):e008405. doi:10.1136/bmjopen-2015-008405
- Sivaprasad S, Hykin P, Prevost AT, et al. Intravitreal Aflibercept Compared with Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: The CLARITY Non-inferiority RCT. Southampton (UK): NIHR Journals Library; 10 2018.